-
Signature
-
/s/ Aimee Weast By Aimee Weast, Attorney in Fact for Jeffrey Henley (POA Filed 03/20/19)
-
Stock symbol
-
ORCL
-
Transactions as of
-
Mar 12, 2024
-
Transactions value $
-
-$34,580,082
-
Form type
-
4
-
Date filed
-
3/14/2024, 04:31 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ORCL |
Common Stock |
Options Exercise |
$16.2M |
+400K |
+36.1% |
$40.47 |
1.51M |
Mar 12, 2024 |
by Trust |
|
transaction |
ORCL |
Common Stock |
Sale |
-$7.64M |
-61K |
-4.04% |
$125.25 |
1.45M |
Mar 12, 2024 |
by Trust |
F1, F2 |
transaction |
ORCL |
Common Stock |
Sale |
-$16M |
-127K |
-8.75% |
$126.26 |
1.32M |
Mar 12, 2024 |
by Trust |
F1, F3 |
transaction |
ORCL |
Common Stock |
Sale |
-$13.6M |
-107K |
-8.08% |
$127.09 |
1.21M |
Mar 12, 2024 |
by Trust |
F1, F4 |
transaction |
ORCL |
Common Stock |
Sale |
-$10.2M |
-79.5K |
-6.55% |
$128.33 |
1.13M |
Mar 12, 2024 |
by Trust |
F1, F5 |
transaction |
ORCL |
Common Stock |
Sale |
-$3.39M |
-26.3K |
-2.32% |
$129.03 |
1.11M |
Mar 12, 2024 |
by Trust |
F1, F6 |
holding |
ORCL |
Common Stock |
|
|
|
|
|
706K |
Mar 12, 2024 |
By GRAT |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ORCL |
Stock Option |
Options Exercise |
$0 |
-400K |
-100% |
$0.00* |
0 |
Mar 12, 2024 |
Common Stock |
400K |
$40.47 |
Direct |
F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: